Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 105034
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.105034
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.105034
Figure 1 The role of cancer-associated fibroblasts in pancreatic cancer progression and the modulatory effects of resveratrol.
This diagram illustrates the dynamic role of cancer-associated fibroblasts (CAFs) in pancreatic cancer progression and highlights the potential of resveratrol in targeting senescent CAFs to disrupt these pro-tumorigenic activities. CAFs: Cancer-associated fibroblasts; SASP: Senescence-associated secretory phenotype; EMT: Epithelial-mesenchymal transition.
- Citation: Qin H. Resveratrol: A promising agent in targeting senescent cancer-associated fibroblasts to inhibit pancreatic cancer progression. World J Gastrointest Oncol 2025; 17(7): 105034
- URL: https://www.wjgnet.com/1948-5204/full/v17/i7/105034.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.105034